InMed Pharmaceuticals Inc. (INM)
USD 1.81
(-14.9%)
USD 1.81
(-14.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 638.29 Million USD | 34.17% |
| 2023 | -8.52 Million USD | -58.29% |
| 2022 | -5.38 Million USD | 24.11% |
| 2021 | -7.09 Million USD | -29.52% |
| 2020 | -5.47 Million CAD | 44.15% |
| 2019 | -9.8 Million CAD | 46.55% |
| 2018 | -18.34 Million CAD | -255.72% |
| 2017 | -5.15 Million CAD | -12202.31% |
| 2016 | -41.92 Thousand CAD | 68.76% |
| 2015 | -134.18 Thousand CAD | -1786.91% |
| 2014 | -7111.32 CAD | -71.69% |
| 2013 | -4141.96 CAD | 90.78% |
| 2012 | -44.9 Thousand CAD | 80.52% |
| 2011 | -230.52 Thousand CAD | -337.49% |
| 2010 | 97.06 Thousand CAD | 68.65% |
| 2009 | 57.55 Thousand CAD | 791.27% |
| 2008 | -8326.00 CAD | 93.48% |
| 2007 | -127.78 Thousand CAD | -289.16% |
| 2006 | 67.55 Thousand CAD | 17.89% |
| 2005 | 57.3 Thousand CAD | -52.95% |
| 2004 | 121.8 Thousand CAD | 642.28% |
| 2003 | 16.4 Thousand CAD | 558.06% |
| 2002 | -3582.27 CAD | 91.26% |
| 2001 | -41 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -8.36 Million USD | -29.83% |
| 2024 Q4 | 638.29 Million USD | 14.1% |
| 2024 Q3 | -6.52 Million USD | 21.97% |
| 2024 Q1 | -6.44 Million USD | 24.36% |
| 2023 Q2 | -10.85 Million USD | -25.46% |
| 2023 Q4 | -8.52 Million USD | 6.44% |
| 2023 FY | -8.52 Million USD | -58.29% |
| 2023 Q3 | -9.1 Million USD | 16.09% |
| 2023 Q1 | -8.65 Million USD | -60.72% |
| 2022 Q3 | -4.97 Million USD | 51.37% |
| 2022 Q4 | -5.38 Million USD | -8.19% |
| 2022 FY | -5.38 Million USD | 24.11% |
| 2022 Q1 | -15.08 Million USD | -112.64% |
| 2022 Q2 | -10.23 Million USD | 32.17% |
| 2021 Q4 | -7.09 Million USD | 22.55% |
| 2021 Q1 | -4.19 Million CAD | 23.49% |
| 2021 Q3 | -9.15 Million USD | 5.63% |
| 2021 FY | -7.09 Million USD | -29.52% |
| 2021 Q2 | -9.7 Million USD | -131.62% |
| 2020 Q1 | -10.73 Million CAD | -9.42% |
| 2020 Q4 | -5.47 Million CAD | 17.63% |
| 2020 Q3 | -6.64 Million CAD | 24.25% |
| 2020 Q2 | -8.77 Million CAD | 18.19% |
| 2020 FY | -5.47 Million CAD | 44.15% |
| 2019 FY | -9.8 Million CAD | 46.55% |
| 2019 Q2 | -11.4 Million CAD | 15.31% |
| 2019 Q3 | -9.68 Million CAD | 15.05% |
| 2019 Q4 | -9.8 Million CAD | -1.26% |
| 2019 Q1 | -13.46 Million CAD | 26.64% |
| 2018 Q2 | -10.31 Million CAD | -112.07% |
| 2018 FY | -18.34 Million CAD | -255.72% |
| 2018 Q4 | -18.35 Million CAD | -105.18% |
| 2018 Q3 | -8.94 Million CAD | 13.28% |
| 2018 Q1 | -4.86 Million CAD | 5.71% |
| 2017 Q2 | -527.35 Thousand CAD | -313.38% |
| 2017 Q1 | -127.57 Thousand CAD | -204.29% |
| 2017 FY | -5.15 Million CAD | -12202.31% |
| 2017 Q4 | -5.15 Million CAD | -151.7% |
| 2017 Q3 | -2.04 Million CAD | -288.57% |
| 2016 Q2 | -31.14 Thousand CAD | -657.08% |
| 2016 Q4 | -41.92 Thousand CAD | -453.72% |
| 2016 Q3 | -7571.42 CAD | 75.69% |
| 2016 FY | -41.92 Thousand CAD | 68.76% |
| 2016 Q1 | -4113.97 CAD | 96.93% |
| 2015 Q4 | -134.18 Thousand CAD | -272.25% |
| 2015 Q2 | 187.85 Thousand CAD | 96.01% |
| 2015 FY | -134.18 Thousand CAD | -1786.91% |
| 2015 Q1 | 95.83 Thousand CAD | 1447.68% |
| 2015 Q3 | 77.9 Thousand CAD | -58.53% |
| 2014 Q3 | -1339.81 CAD | -51.44% |
| 2014 Q1 | -1431.78 CAD | 65.43% |
| 2014 FY | -7111.32 CAD | -71.69% |
| 2014 Q4 | -7111.32 CAD | -430.77% |
| 2014 Q2 | -884.70 CAD | 38.21% |
| 2013 Q4 | -4141.96 CAD | -85.0% |
| 2013 Q3 | -2238.93 CAD | 3.41% |
| 2013 Q2 | -2317.98 CAD | 87.5% |
| 2013 Q1 | -18.54 Thousand CAD | 58.7% |
| 2013 FY | -4141.96 CAD | 90.78% |
| 2012 Q3 | -89.3 Thousand CAD | 12.86% |
| 2012 Q1 | -175.08 Thousand CAD | 24.05% |
| 2012 Q2 | -102.48 Thousand CAD | 41.47% |
| 2012 FY | -44.9 Thousand CAD | 80.52% |
| 2012 Q4 | -44.9 Thousand CAD | 49.72% |
| 2011 Q1 | 103.04 Thousand CAD | 6.16% |
| 2011 FY | -230.52 Thousand CAD | -337.49% |
| 2011 Q4 | -230.52 Thousand CAD | 61.01% |
| 2011 Q3 | -591.18 Thousand CAD | -635.98% |
| 2011 Q2 | 110.3 Thousand CAD | 7.04% |
| 2010 Q2 | 159.74 Thousand CAD | 36.15% |
| 2010 Q3 | 211.07 Thousand CAD | 32.13% |
| 2010 Q4 | 97.06 Thousand CAD | -54.01% |
| 2010 FY | 97.06 Thousand CAD | 68.65% |
| 2010 Q1 | 117.33 Thousand CAD | 103.86% |
| 2009 Q4 | 57.55 Thousand CAD | 38.16% |
| 2009 FY | 57.55 Thousand CAD | 791.27% |
| 2009 Q3 | 41.65 Thousand CAD | 152.89% |
| 2009 Q2 | 16.47 Thousand CAD | -49.15% |
| 2009 Q1 | 32.39 Thousand CAD | 489.13% |
| 2008 Q2 | -209.19 Thousand CAD | -37.18% |
| 2008 Q3 | -70.77 Thousand CAD | 66.17% |
| 2008 Q4 | -8325.80 CAD | 88.24% |
| 2008 FY | -8325.80 CAD | 93.48% |
| 2008 Q1 | -152.48 Thousand CAD | -19.34% |
| 2007 Q2 | 77.15 Thousand CAD | 41.29% |
| 2007 Q1 | 54.6 Thousand CAD | -19.16% |
| 2007 FY | -127.78 Thousand CAD | -289.16% |
| 2007 Q4 | -127.78 Thousand CAD | 59.5% |
| 2007 Q3 | -315.53 Thousand CAD | -508.99% |
| 2006 Q3 | 44.29 Thousand CAD | -79.32% |
| 2006 FY | 67.55 Thousand CAD | 17.89% |
| 2006 Q2 | 214.17 Thousand CAD | 691596.02% |
| 2006 Q1 | 30.96 CAD | -99.95% |
| 2006 Q4 | 67.55 Thousand CAD | 52.51% |
| 2005 Q2 | 1.86 Million CAD | 1317.33% |
| 2005 Q3 | 889.14 Thousand CAD | -52.22% |
| 2005 Q4 | 57.3 Thousand CAD | -93.56% |
| 2005 FY | 57.3 Thousand CAD | -52.95% |
| 2005 Q1 | 131.3 Thousand CAD | 7.8% |
| 2004 Q2 | 45.93 Thousand CAD | 494.77% |
| 2004 Q4 | 121.8 Thousand CAD | 211.25% |
| 2004 FY | 121.8 Thousand CAD | 642.28% |
| 2004 Q1 | -11.63 Thousand CAD | -170.91% |
| 2004 Q3 | 39.13 Thousand CAD | -14.8% |
| 2003 FY | 16.4 Thousand CAD | 558.06% |
| 2003 Q4 | 16.4 Thousand CAD | 184.8% |
| 2003 Q2 | -15.33 Thousand CAD | 47.1% |
| 2003 Q1 | -28.99 Thousand CAD | -709.48% |
| 2003 Q3 | -19.34 Thousand CAD | -26.14% |
| 2002 Q2 | -17.51 Thousand CAD | -1896.75% |
| 2002 Q1 | -877.24 CAD | 0.0% |
| 2002 Q4 | -3582.27 CAD | 83.07% |
| 2002 Q3 | -21.16 Thousand CAD | -20.82% |
| 2002 FY | -3582.27 CAD | 91.26% |
| 2001 FY | -41 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 1241.032% |
| Alkermes plc | -166.73 Million USD | 482.81% |
| Agenus Inc. | 274.13 Million USD | -132.838% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 65.866% |
| Aptorum Group Limited | 1.35 Million USD | -46935.501% |
| Ardelyx, Inc. | 34.51 Million USD | -1749.482% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -14813.397% |
| Bicycle Therapeutics plc | -481.46 Million USD | 232.573% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -1665.045% |
| ChromaDex Corporation | -24.04 Million USD | 2754.247% |
| Chimerix, Inc. | -25.51 Million USD | 2601.444% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -9060.253% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 2795.837% |
| CRISPR Therapeutics AG | -150.84 Million USD | 523.145% |
| Precision BioSciences, Inc. | -85.41 Million USD | 847.329% |
| Dyadic International, Inc. | -6.37 Million USD | 10107.58% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 4106.109% |
| Fortress Biotech, Inc. | 7.66 Million USD | -8227.376% |
| Lantern Pharma Inc. | -21.7 Million USD | 3041.0% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 677.448% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 7571.383% |
| Incyte Corporation | -3.17 Billion USD | 120.103% |
| IO Biotech, Inc. | -140.69 Million USD | 553.659% |
| Jaguar Health, Inc. | 29.39 Million USD | -2071.731% |
| Novavax, Inc. | -298.29 Million USD | 313.981% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -11859.779% |
| Opthea Limited | 28.15 Million USD | -2166.873% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 3901.855% |
| ContextLogic Inc. | -232 Million USD | 375.126% |
| MiMedx Group, Inc. | -33.9 Million USD | 1982.816% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -6160.847% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 27647.948% |
| NextCure, Inc. | -6.47 Million USD | 9954.769% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 1363.922% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 10106.167% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -5147.713% |
| Vaxcyte, Inc. | -368.22 Million USD | 273.342% |
| PDS Biotechnology Corporation | -32.7 Million USD | 2051.436% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -3594.255% |
| Pharming Group N.V. | 109.8 Million USD | -481.302% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 3769.196% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 464.26% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3546.535% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3546.535% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 9090.048% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 10992.379% |
| Acelyrin, Inc. | -216.9 Million USD | 394.276% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 11477.237% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 37123.979% |
| Summit Therapeutics Inc. | 34.67 Million USD | -1740.842% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 9482.528% |
| Senti Biosciences, Inc. | 1.74 Million USD | -36583.528% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 445.758% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 924.125% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 10629.419% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -639671.262% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -101539.075% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 645.336% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 479.41% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -475.713% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 8503.02% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 594.364% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -9157.877% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 363.363% |
| Immix Biopharma, Inc. | -17.5 Million USD | 3745.351% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 301.543% |
| MEI Pharma, Inc. | -3.7 Million USD | 17327.892% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -5001.857% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -294.637% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -2196.598% |
| Fortress Biotech, Inc. | 7.66 Million USD | -8227.376% |
| Precigen, Inc. | -481 Thousand USD | 132801.328% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -4433.012% |
| AlloVir, Inc. | -62.69 Million USD | 1118.142% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 1247.721% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -935.082% |
| ImmuCell Corporation | 10.99 Million USD | -5707.65% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 514.084% |
| Onconetix, Inc. | 5.33 Million USD | -11872.258% |
| PureTech Health plc | -167.19 Million USD | 481.761% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 2195.513% |
| Elevation Oncology, Inc. | -19.11 Million USD | 3438.704% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 13102.514% |
| Seer, Inc. | -4.24 Million USD | 15154.089% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 2755.462% |
| Innoviva, Inc. | 255.56 Million USD | -149.76% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 1242.584% |
| ESSA Pharma Inc. | -33.62 Million USD | 1998.463% |
| GlycoMimetics, Inc. | -40.98 Million USD | 1657.405% |
| GT Biopharma, Inc. | -1.02 Million USD | 62616.493% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 1041.672% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -941.993% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 576.058% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 4706.621% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 2310.77% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 847384.613% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 2168.218% |
| Aptose Biosciences Inc. | -8.19 Million USD | 7888.951% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 20499.16% |
| Soligenix, Inc. | -4.95 Million USD | 12990.657% |
| Century Therapeutics, Inc. | 847 Thousand USD | -75259.314% |
| Kura Oncology, Inc. | -20.11 Million USD | 3272.748% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 1659.628% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 7700.54% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -34938.433% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 20065.386% |
| Autolus Therapeutics plc | -186.59 Million USD | 442.067% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 1394.608% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 331.438% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -1762.651% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -288.332% |
| GRI Bio, Inc. | -1.79 Million USD | 35679.342% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 7205.534% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 2019.275% |
| IGM Biosciences, Inc. | -72.6 Million USD | 979.119% |
| INmune Bio, Inc. | -25.41 Million USD | 2611.878% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -322.848% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1359.98% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4028.111% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 22225.122% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -1579.057% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 1649.82% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -1901.861% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -68.883% |
| Verastem, Inc. | -37.27 Million USD | 1812.252% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 7135.086% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 1330.754% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 4317.333% |
| Histogen Inc. | -7.48 Million USD | 8625.356% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 3054.129% |
| Surrozen, Inc. | -32.66 Million USD | 2054.119% |
| Organovo Holdings, Inc. | -1.5 Million USD | 42455.235% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 15284.851% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -3266.489% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -24299.594% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -15258.359% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 7715.821% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 1569.3% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 4478.813% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 301.488% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 88498.941% |
| Apollomics, Inc. | -27.39 Million USD | 2429.963% |
| Amarin Corporation plc | -191.04 Million USD | 434.115% |
| Mesoblast Limited | 55.96 Million USD | -1040.563% |
| Turnstone Biologics Corp. | -14.58 Million USD | 4476.669% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 2623.697% |
| Synaptogenix, Inc. | -28.66 Million USD | 2327.006% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 68293.738% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -1209.803% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 74140.313% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 8884.563% |
| Exelixis, Inc. | -73.05 Million USD | 973.776% |
| Better Therapeutics, Inc. | -860 Thousand USD | 74320.162% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 2758.116% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 364.445% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -86616.869% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 8681.363% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -50800.589% |
| Gritstone bio, Inc. | 39.49 Million USD | -1516.342% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 858.961% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 24349.979% |
| Avid Bioservices, Inc. | 169.72 Million USD | -276.068% |
| Insmed Incorporated | 721.62 Million USD | 11.547% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 7082.361% |
| MediWound Ltd. | -5.32 Million USD | 12093.487% |
| OmniAb, Inc. | 9.2 Million USD | -6835.71% |
| Alector, Inc. | -35.63 Million USD | 1891.097% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -642.452% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 13052.382% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -4721.311% |
| Zai Lab Limited | -775 Million USD | 182.36% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -87.427% |
| Aura Biosciences, Inc. | -21.52 Million USD | 3065.358% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 873.877% |
| Immunic, Inc. | -45.34 Million USD | 1507.793% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 430.354% |
| Veracyte, Inc. | -203.82 Million USD | 413.159% |
| FibroGen, Inc. | 56.76 Million USD | -1024.409% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -7067.809% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 22677.817% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 30930.246% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 86.095% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 19204.861% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 484.597% |
| TG Therapeutics, Inc. | 17.86 Million USD | -3473.471% |
| Galecto, Inc. | -21.21 Million USD | 3108.547% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 2783.596% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 59.329% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 2708.26% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 5647.001% |
| XBiotech Inc. | -200.02 Million USD | 419.11% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 858.961% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -13996.585% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1910.094% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 926.612% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -11115.839% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 474.552% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 790.988% |
| Vaxxinity, Inc. | 10.13 Million USD | -6199.777% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 13.307% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 6027.935% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 1067.756% |
| NexImmune, Inc. | -3.13 Million USD | 20469.053% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 18586.934% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 4323.906% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 2455.326% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 7211.07% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 512476.793% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 1673.236% |
| Ainos, Inc. | 4.07 Million USD | -15552.395% |
| Pluri Inc. | 22.82 Million USD | -2695.976% |
| Prothena Corporation plc | -608.34 Million USD | 204.923% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 637.483% |
| Celularity Inc. | 65.19 Million USD | -879.128% |
| Rallybio Corporation | -24.1 Million USD | 2748.301% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1987.381% |
| MeiraGTx Holdings plc | -40.3 Million USD | 1683.776% |
| Omeros Corporation | 331.17 Million USD | -92.735% |
| Humacyte, Inc. | -22.48 Million USD | 2938.626% |
| Immunocore Holdings plc | -358.59 Million USD | 277.999% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 2697.328% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 2165.608% |
| Blueprint Medicines Corporation | 702.83 Million USD | 9.183% |
| CalciMedica, Inc. | -5.53 Million USD | 11642.376% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 439.121% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 6349.201% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 1694.259% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 2019.506% |
| Pulmatrix, Inc. | -10.41 Million USD | 6227.42% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 10779.16% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1773.466% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 672.964% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 1164.816% |
| Cytokinetics, Incorporated | 642.37 Million USD | 0.635% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 11061.59% |
| Nutriband Inc. | -251.65 Thousand USD | 253736.255% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1970.786% |
| Vor Biopharma Inc. | 4.3 Million USD | -14744.032% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 110.575% |
| Evogene Ltd. | -19.63 Million USD | 3350.96% |
| ProKidney Corp. | -56.23 Million USD | 1235.026% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 1411.418% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 7010.041% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 53.201% |
| CorMedix Inc. | -43.05 Million USD | 1582.593% |
| BioLineRx Ltd. | 7.33 Million USD | -8600.837% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 2424.025% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -1283.174% |
| Atai Life Sciences N.V. | -28.55 Million USD | 2335.077% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -28516.234% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 2897.569% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -3499.061% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 950.219% |
| MediciNova, Inc. | -50.78 Million USD | 1356.891% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 909.966% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 2837590.064% |
| GeoVax Labs, Inc. | -6.45 Million USD | 9992.051% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 419.433% |
| Biomea Fusion, Inc. | -166.57 Million USD | 483.198% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 456.638% |
| Mereo BioPharma Group plc | -51.46 Million USD | 1340.151% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 772.993% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 317.285% |
| Absci Corporation | -72.59 Million USD | 979.216% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -13879.268% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 372.266% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 777.515% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 767.001% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 1733.592% |
| Allakos Inc. | -24.97 Million USD | 2655.729% |
| Imunon, Inc. | -4.21 Million USD | 15247.504% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 4429.761% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 571.413% |
| BioAtla, Inc. | -109.01 Million USD | 685.531% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -86616.869% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 68075.867% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -5234.225% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 3110.392% |
| XOMA Corporation | -29 Million USD | 2301.012% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 3954.429% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 7179.563% |
| aTyr Pharma, Inc. | -7.44 Million USD | 8668.847% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 612.126% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 406.63% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 880.51% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 788.09% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 74390.651% |
| Akari Therapeutics, Plc | -3.84 Million USD | 16700.608% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -39230.663% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 53.776% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 53822.295% |
| UroGen Pharma Ltd. | 4.39 Million USD | -14436.402% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -462.467% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -886886.729% |
| Orgenesis Inc. | 21.78 Million USD | -2830.102% |
| Entera Bio Ltd. | -10.62 Million USD | 6105.206% |
| GH Research PLC | -78.07 Million USD | 917.518% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 2963.843% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 2494.289% |
| Xencor, Inc. | 29.64 Million USD | -2053.196% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 32503.772% |
| Replimune Group, Inc. | 1.41 Million USD | -45104.914% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 260725.782% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 604.911% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 53822.295% |
| Portage Biotech Inc. | -4.98 Million USD | 12914.563% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 2837590.064% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 1065.327% |
| OncoCyte Corporation | -6.56 Million USD | 9825.634% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -71025.935% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 14111.049% |
| Purple Biotech Ltd. | -14.13 Million USD | 4614.736% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 2786.872% |
| scPharmaceuticals Inc. | -6.54 Million USD | 9852.382% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 3923.91% |
| HilleVax, Inc. | -165.48 Million USD | 485.711% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 25249.464% |
| Tharimmune, Inc. | -10.93 Million USD | 5936.972% |
| Genprex, Inc. | -6.73 Million USD | 9573.561% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 273.07% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 821.562% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 45659.842% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 19343.406% |
| OKYO Pharma Limited | -826.84 Thousand USD | 77295.977% |
| Savara Inc. | 153 Thousand USD | -417085.222% |
| Curis, Inc. | -23.88 Million USD | 2772.137% |
| Daré Bioscience, Inc. | -5.15 Million USD | 12475.037% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 82353.031% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 10381.788% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -53764.421% |
| BeiGene, Ltd. | -2.25 Billion USD | 128.33% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -5073.185% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 204.947% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 443.934% |
| Erasca, Inc. | -37.21 Million USD | 1815.105% |
| bluebird bio, Inc. | 108.57 Million USD | -487.904% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 49661.057% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -68.527% |
| DBV Technologies S.A. | -126.98 Million USD | 602.649% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 49661.057% |
| Moderna, Inc. | -2.9 Billion USD | 121.957% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 6265.894% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 5973.145% |
| Molecular Templates, Inc. | 707 Thousand USD | -90181.95% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 2134.661% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -84.154% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 877.818% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 795.839% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 2077.855% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1956.799% |
| MacroGenics, Inc. | -66.98 Million USD | 1052.89% |
| RenovoRx, Inc. | -1.17 Million USD | 54515.464% |
| Adicet Bio, Inc. | -138.78 Million USD | 559.909% |
| Prime Medicine, Inc. | -27.94 Million USD | 2384.433% |
| Aditxt, Inc. | 18.12 Million USD | -3422.418% |
| Adagene Inc. | -87.62 Million USD | 828.418% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 15423.597% |
| Quantum-Si incorporated | -118.55 Million USD | 638.385% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -1672.791% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 8639.97% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 1415.825% |
| SciSparc Ltd. | -2.06 Million USD | 31010.092% |
| Vericel Corporation | 1.27 Million USD | -49883.821% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5422.793% |
| Minerva Neurosciences, Inc. | 41 Million USD | -1456.652% |
| Generation Bio Co. | 31.44 Million USD | -1929.679% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 463.982% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 2164.138% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -447.454% |
| Invivyd, Inc. | -198.47 Million USD | 421.597% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 807.094% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 26721.2% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 1001.672% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 9452.284% |
| 2seventy bio, Inc. | 181.71 Million USD | -251.261% |
| ADMA Biologics, Inc. | 90.06 Million USD | -608.695% |
| Clene Inc. | 3.34 Million USD | -19010.581% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 7127.571% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 3067.288% |
| GeoVax Labs, Inc. | -6.45 Million USD | 9992.051% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 285.484% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 2555.005% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -259.266% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 15700.218% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -12660.763% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 12353.665% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 589.849% |
| Evaxion Biotech A/S | 5.28 Million USD | -11973.24% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 667.029% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 586.234% |
| Trevena, Inc. | 2.25 Million USD | -28168.086% |
| Surrozen, Inc. | -32.66 Million USD | 2054.119% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 1339.164% |
| Cingulate Inc. | 3.08 Million USD | -20605.774% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 21832.836% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -8781.222% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 6969.85% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 904.676% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 585.571% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 704.777% |
| Clearmind Medicine Inc. | -3.94 Million USD | 16289.504% |
| Kronos Bio, Inc. | -36.05 Million USD | 1870.382% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -6683.86% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -43674.883% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 1276.448% |
| Statera Biopharma, Inc. | 14.41 Million USD | -4327.549% |
| ImmunityBio, Inc. | 618.22 Million USD | -3.246% |
| Korro Bio, Inc. | -132.94 Million USD | 580.126% |
| Kineta, Inc. | -4.54 Million USD | 14156.23% |
| BioVie Inc. | -17.73 Million USD | 3699.598% |
| Codexis, Inc. | -43.27 Million USD | 1575.107% |
| Celularity Inc. | 65.19 Million USD | -879.128% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 20241.792% |
| Celcuity Inc. | 6.78 Million USD | -9309.487% |
| Virax Biolabs Group Limited | -3.36 Million USD | 19068.916% |
| Cibus, Inc. | -8.07 Million USD | 8001.627% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 15193.246% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -13867.033% |
| IN8bio, Inc. | -16.38 Million USD | 3994.645% |
| Kodiak Sciences Inc. | -103.87 Million USD | 714.482% |
| Annexon, Inc. | -193.75 Million USD | 429.433% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -1772937.194% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 3747.599% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 18269.467% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 39.457% |
| Eyenovia, Inc. | 1.25 Million USD | -50610.445% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -2272.397% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 19782.189% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 2019.853% |
| Arcellx, Inc. | -296.95 Million USD | 314.944% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 3372.293% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 1184.15% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 3179.526% |
| Moolec Science SA | 117.61 Thousand USD | -542592.652% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1762.266% |
| Geron Corporation | 14.76 Million USD | -4224.188% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 1783.352% |
| Royalty Pharma plc | 5.65 Billion USD | 88.719% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 551.343% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 9232.275% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 12002.11% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 553.556% |
| Humacyte, Inc. | -22.48 Million USD | 2938.626% |
| Structure Therapeutics Inc. | -124.33 Million USD | 613.349% |
| 89bio, Inc. | -289.05 Million USD | 320.822% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 2628.696% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 35898.844% |
| Genelux Corporation | -6.89 Million USD | 9351.97% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 2155.1% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -663.518% |
| Notable Labs, Ltd. | -9.77 Million USD | 6629.188% |
| Liquidia Corporation | -80.17 Million USD | 896.115% |
| Mustang Bio, Inc. | -3.73 Million USD | 17184.941% |
| Immunovant, Inc. | -635.22 Million USD | 200.483% |
| Quantum-Si incorporated | -118.55 Million USD | 638.385% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 3734.1% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 15506.551% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -7851.83% |
| Acasti Pharma Inc. | -23 Million USD | 2874.585% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 19056.043% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4028.111% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 563.405% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 20582.004% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 2971.057% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 3537.414% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 477.068% |
| PepGen Inc. | -60.67 Million USD | 1152.074% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 2878.088% |
| United Therapeutics Corporation | -507.7 Million USD | 225.723% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 3437.307% |
| Solid Biosciences Inc. | -47.75 Million USD | 1436.74% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 74140.313% |
| Immuneering Corporation | -54.94 Million USD | 1261.74% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 15284.851% |
| Silo Pharma, Inc. | -3.52 Million USD | 18211.169% |
| Belite Bio, Inc | -87.27 Million USD | 831.392% |
| XOMA Corporation | -29 Million USD | 2301.012% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 1002.858% |
| Bionomics Limited | 227 Million USD | -181.174% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 648.918% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 25299.107% |
| uniQure N.V. | -102.95 Million USD | 719.997% |
| Cassava Sciences, Inc. | -121.13 Million USD | 626.923% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 15423.597% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -1458.676% |
| Forte Biosciences, Inc. | -11.96 Million USD | 5436.455% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 20728.705% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -602063.575% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 19782.189% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -7067.809% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 8706.977% |
| Altimmune, Inc. | -134.48 Million USD | 574.613% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -222.265% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 25299.107% |
| Compugen Ltd. | -12.9 Million USD | 5046.477% |
| Peak Bio, Inc. | 10.34 Million USD | -6072.956% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 225645.367% |
| Benitec Biopharma Inc. | -50.58 Million USD | 1361.898% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 711.755% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -3149.139% |
| Zura Bio Limited | -99.8 Million USD | 739.534% |
| PolyPid Ltd. | 6.17 Million USD | -10245.112% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -761.162% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -3149.139% |
| Instil Bio, Inc. | 75.35 Million USD | -747.015% |
| argenx SE | -2.02 Billion USD | 131.461% |
| Immunome, Inc. | -97.02 Million USD | 757.838% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 2937.49% |
| Verona Pharma plc | -220.44 Million USD | 389.55% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 989.694% |
| Shattuck Labs, Inc. | -121.42 Million USD | 625.673% |
| CervoMed Inc. | -7.79 Million USD | 8290.761% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 444.095% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 14696.236% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 584.51% |
| Moolec Science SA | 117.61 Thousand USD | -542592.652% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 27997.719% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -3914.833% |
| AnaptysBio, Inc. | -18.15 Million USD | 3616.574% |
| Design Therapeutics, Inc. | -18.15 Million USD | 3616.768% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 1006.912% |
| NeurAxis, Inc. | 145.7 Thousand USD | -437987.433% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -5582.812% |
| Lumos Pharma, Inc. | -28.49 Million USD | 2340.176% |
| Achilles Therapeutics plc | -126.92 Million USD | 602.894% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 989.694% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 97440.886% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 3172.585% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -43674.883% |
| Nutriband Inc. | -251.65 Thousand USD | 253736.255% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 4946.203% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 8679.212% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -87.625% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -2589.25% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 242.644% |
| Palisade Bio, Inc. | -12.06 Million USD | 5391.332% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 554.913% |
| Beam Therapeutics Inc. | -262.72 Million USD | 342.954% |
| Neurogene Inc. | -131.95 Million USD | 583.721% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -2825.804% |
| AEON Biopharma, Inc. | -4.88 Million USD | 13179.783% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 269.223% |
| Sesen Bio, Inc. | -112.55 Million USD | 667.105% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 739.188% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 27286.953% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 1735.559% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 866.424% |
| Athira Pharma, Inc. | -88.99 Million USD | 817.192% |
| Vaccinex, Inc. | -1.28 Million USD | 49656.94% |
| HCW Biologics Inc. | 2.85 Million USD | -22243.92% |
| XOMA Corporation | -29 Million USD | 2301.012% |
| Nektar Therapeutics | 210.24 Million USD | -203.602% |
| Arvinas, Inc. | -313.8 Million USD | 303.408% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -39230.663% |
| Merus N.V. | -192.88 Million USD | 430.921% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -964.088% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 9299.962% |
| Rezolute, Inc. | -68.16 Million USD | 1036.353% |
| Clene Inc. | 3.34 Million USD | -19010.581% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 4940.323% |
| BeyondSpring Inc. | -13.75 Million USD | 4740.446% |
| Synlogic, Inc. | -6.68 Million USD | 9648.143% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -56186.895% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 7649.301% |
| Peak Bio, Inc. | 10.34 Million USD | -6072.956% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 874.44% |
| Krystal Biotech, Inc. | -350.23 Million USD | 282.248% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -414.234% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 477.697% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 20317.43% |
| MannKind Corporation | 143.89 Million USD | -343.57% |
| Ikena Oncology, Inc. | -109.15 Million USD | 684.753% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 8530.767% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 2028.379% |
| Gossamer Bio, Inc. | 180.35 Million USD | -253.909% |
| CohBar, Inc. | -5.93 Million USD | 10862.474% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 2245.668% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -13879.268% |
| Legend Biotech Corporation | -949.39 Million USD | 167.231% |
| Mural Oncology plc | -255.84 Million USD | 349.486% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -1881.355% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 13650.03% |
| Disc Medicine, Inc. | -358.28 Million USD | 278.154% |
| Champions Oncology, Inc. | 4.81 Million USD | -13164.617% |
| REGENXBIO Inc. | 54.76 Million USD | -1065.45% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 237465.851% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 522.644% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 7182.7% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 891.113% |
| Vaxart, Inc. | -8.24 Million USD | 7845.339% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 1372.008% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 601.939% |
| Cellectis S.A. | -43.85 Million USD | 1555.463% |
| Longeveron Inc. | -2.9 Million USD | 22049.566% |
| Repare Therapeutics Inc. | -107.85 Million USD | 691.79% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 34.086% |
| Inozyme Pharma, Inc. | 12 Million USD | -5217.339% |
| Revolution Medicines, Inc. | -608.2 Million USD | 204.947% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 51993.772% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 340.759% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 525.325% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 4179.334% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 86355.864% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 106.674% |
| Denali Therapeutics Inc. | -74.86 Million USD | 952.593% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5422.793% |
| Veru Inc. | 4.77 Million USD | -13253.505% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 5775.737% |
| Cingulate Inc. | 3.08 Million USD | -20605.774% |
| Passage Bio, Inc. | 4.58 Million USD | -13821.339% |
| Context Therapeutics Inc. | -14.44 Million USD | 4517.308% |
| Exicure, Inc. | 5.84 Million USD | -10812.864% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 377.066% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 1713.074% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -3967.895% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 1185.145% |
| Nuvalent, Inc. | -335.38 Million USD | 290.315% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -36703.223% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 956.977% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 7279.903% |
| OmniAb, Inc. | 9.2 Million USD | -6835.71% |
| Anew Medical, Inc. | 1.43 Million USD | -44459.091% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -3796.368% |
| Lipocine Inc. | -4.75 Million USD | 13524.777% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 681.175% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -4090.752% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1359.98% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -2464.251% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 9597.0% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 1069.653% |
| Ocugen, Inc. | -32.52 Million USD | 2062.711% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 845.888% |
| Q32 Bio Inc. | -37.94 Million USD | 1782.021% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 101739.075% |
| Alumis Inc. Common Stock | -13.52 Million USD | 4817.964% |
| Equillium, Inc. | -22.39 Million USD | 2950.542% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 2596.454% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 2056.349% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 257564.611% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -376.189% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -19859.143% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -194240.35% |
| Dominari Holdings Inc. | 195 Thousand USD | -327229.944% |
| Edesa Biotech, Inc. | -5.26 Million USD | 12218.935% |
| vTv Therapeutics Inc. | -8.91 Million USD | 7258.163% |
| Bio-Techne Corporation | 267.74 Million USD | -138.394% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 4037.895% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 640.496% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 7696.018% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 5145.399% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 360.401% |
| Nkarta, Inc. | 57.29 Million USD | -1013.97% |
| BioCardia, Inc. | 212 Thousand USD | -300981.788% |
| Iterum Therapeutics plc | 13.43 Million USD | -4649.914% |